Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paxlovid in COVID-19 Patients With Severe Chronic Kidney Disease
NCT05938140Phase 4Unknown
- Sponsor
- Chinese PLA General Hospital
- Start
- Jun 2023
- Primary completion
- May 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of Nirmatrelvir in coronavirus disease 2019 (COVID-19), sponsored by Chinese PLA General Hospital. Status: unknown.
02
Drugs
Nirmatrelvir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05938140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05938140.